Location

Berlin
Neuendorfstraße 20b
D-16761 Hennigsdorf / Berlin

Switzerland
Bleicherweg 45
8002 Zurich

Home

MetrioPharm AG is a biopharmaceutical company working on the development of small molecular drugs based on the functional principle of immune and metabolic modulation. Our current pipeline targets acute and chronic diseases in the areas of

inflammation
infection
auto–immune
cardiovascular

Our drug compounds have already demonstrated efficacy and safety in man in a variety of clinical applications such as bacterial infections, hepatitis (B&C), chronic inflammatory diseases, wound healing, psoriasis and chronic heart failure.